Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume 57, Issue 2, Pages 215-223
Publisher
Springer Science and Business Media LLC
Online
2021-11-08
DOI
10.1038/s41409-021-01515-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Defining the Role of Donor Lymphocyte Infusion in High-Risk Hematologic Malignancies
- (2021) Christoph Schmid et al. JOURNAL OF CLINICAL ONCOLOGY
- Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT
- (2020) Arnon Nagler et al. BONE MARROW TRANSPLANTATION
- Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS post-allogeneic transplant.
- (2020) Premal Lulla et al. BLOOD
- Biology-driven approaches to prevent and treat relapse of myeloid neoplasia after allogeneic hematopoietic stem cell transplantation
- (2019) Robert Zeiser et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome
- (2019) Thierry Guillaume et al. BONE MARROW TRANSPLANTATION
- Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
- (2018) Nimitha R Mathew et al. NATURE MEDICINE
- Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
- (2018) Catherine J. Lee et al. BONE MARROW TRANSPLANTATION
- Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT
- (2018) Christoph Schmid et al. BRITISH JOURNAL OF HAEMATOLOGY
- Improved Outcome of Refractory/Relapsed Acute Myeloid Leukemia after Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation with Myeloablative Conditioning and Early Prophylactic Granulocyte Colony-Stimulating Factor–Mobilized Donor Lymphocyte Infusions
- (2016) Sarita Rani Jaiswal et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT
- (2016) P Tsirigotis et al. BONE MARROW TRANSPLANTATION
- Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation
- (2015) Z Jedlickova et al. BONE MARROW TRANSPLANTATION
- In adults with t(8;21)AML, posttransplant RUNX1/RUNX1T1-based MRD monitoring, rather than c-KIT mutations, allows further risk stratification
- (2014) Y. Wang et al. BLOOD
- Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL
- (2013) M Eefting et al. BONE MARROW TRANSPLANTATION
- Risk-adapted donor lymphocyte infusion based on chimerism and donor source in pediatric leukemia
- (2013) P Rujkijyanont et al. Blood Cancer Journal
- Monitoring and Prevention of Relapse after Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancies
- (2012) Ulrike Bacher et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- High Alloreactivity of Low-Dose Prophylactic Donor Lymphocyte Infusion in Patients with Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation with an Alemtuzumab-Containing Conditioning Regimen
- (2012) Maria Liga et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation
- (2012) C.-H. Yan et al. BLOOD
- Prevention of relapse using DLI can increase survival following HLA-identical transplantation in patients with advanced-stage acute leukemia: a multi-center study
- (2012) Yu Wang et al. CLINICAL TRANSPLANTATION
- Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation
- (2011) E. Rettinger et al. BLOOD
- Modified Donor Lymphocyte Infusion (DLI) for the Prophylaxis of Leukemia Relapse after Hematopoietic Stem Cell Transplantation in Patients with Advanced Leukemia—Feasibility and Safety Study
- (2008) Xiao-Jun Huang et al. JOURNAL OF CLINICAL IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started